Dietary determinants of serum paraoxonase activity in healthy humans

doi:10.1016/S0021-9150(01)00594-9

Atherosclerosis

Volume 160, Issue 2, February 2002, Pages 425-432

https://doi.org/10.1016/S0021-9150(01)00594-9 Get rights and content

Abstract

The associations between habitual diet and a variety of markers of lipid peroxidation or oxidative stress in a group of 95 healthy comparatively young Finnish volunteers (24 male and 71 females) were investigated. The habitual diet of the subjects was evaluated with a 3-day food record. The following biochemical parameters related to lipid peroxidation or oxidative stress were measured: lagtime of Cu²⁺ induced LDL oxidation in vitro, lipid hydroperoxides and Schiff bases produced during the LDL oxidation test, malondialdehyde measured as thiobarbituric acid-reactive substances from native LDL and Cu²⁺ oxidized LDL, serum paraoxonase (PON) activity. Serum PON activity showed most constantly associations with habitual diet. PON activity correlated negatively (r=−0.31 to −0.37) with intake of vegetables, total and water-soluble fiber, as well as intake of β-carotene. Highly significant difference (P=0.005) in PON activity between lowest (<135 g/day) and highest (>256 g/day) vegetable intake quartiles was found. Malondialdehyde levels showed conflicting associations with diet. The results suggest that the significantly lower PON activity associated with high vegetable intake needs to be studied further.

Introduction

Oxidative stress has been implicated in the pathogenesis of a wide variety of human diseases including atherosclerosis, cancer, rheumatic and neurodegenerative diseases. It may arise in tissues or body fluids when the levels of reactive oxygen species overcome the levels of protective enzymatic or antioxidant defense systems. Oxidized low density lipoprotein (LDL) is believed to play an important role in the events associated with the initiation of atheroslcerosis. High density lipoproteins (HDL) have been shown to prevent oxidative modification of LDL in vitro [1], as well as in vivo [2]. There are studies, which indicate that two enzymes associated with HDL, paraoxonase (PON) and platelet-activating factor acetylhydrolase are responsible for its antioxidative and anti-inflammatory properties [3], [4]. In vitro studies indicate that PON can significantly lower lipid peroxide generation during LDL oxidation and, therefore, may provide HDL-associated protection against atherosclerotic process.

The role of diet in pro-and antioxidative processes is an intriguing concept and, at least in theory, diet can both increase (by e.g. polyunsaturated fatty acids, PUFA) and decrease (e.g. by antioxidants) oxidative stress in the body. Unfortunately, studies in this area are still hampered due to the lack of proper indicators of increased oxidation in vivo. However, dietary PUFA has been shown to increase LDL oxidation in vitro in several human interventions [5]. Furthermore, increased in vivo lipid peroxidation measured as urinary 8-iso-prostaglandin F_2α (8-iso-PGF_2α) has been reported after high PUFA diet [6] or after intake of conjugated linoleic acid [7]. Also DNA etheno adduct formation has been increased with high-linoleic acid diet in a strictly controlled intervention [8] which indicates a possible pro-oxidative effect of high PUFA diet in humans. On the other hand, increased intake of dietary antioxidants, often in pharmacological quantities, may suppress oxidative damage to lipids, proteins, and DNA [9].

Data in humans is largely based on experimental studies in which the intakes of PUFA or vitamins usually are higher than in the habitual diet of the human subjects. So far, studies on the associations between habitual diet and markers of oxidation are few. High proportion of n-3 PUFA in LDL [10] or high intake of n-6 PUFA [11] have shown to be associated with increased LDL oxidation in vitro. In a French study focusing on the effect of smoking on health status, habitual food intake was analyzed from 459 healthy subjects and plasma antioxidants and some parameters for lipid peroxidation were measured. Unfortunately associations between oxidation markers and dietary data were not reported [12].

We have analyzed the associations between habitual diet and a variety of markers of lipid peroxidation or oxidative stress in a group of 95 healthy comparatively young Finnish volunteers. The study was carried out at the beginning of a large controlled human intervention designed to study the effects of natural antioxidant compounds from vegetables, berries and apple and dietary unsaturated fatty acids on several markers associated with the risk of coronary heart disease (CHD) and cancer.

Section snippets

Subjects

Study subjects were students and employees from the Viikki campus of the University of Helsinki. The health status of the participants was checked with a questionnaire and screening tests (body weight and height, blood pressure, urinary glucose and protein). As a final outcome, 24 apparently healthy male and 71 female volunteers participated in the study. Four of the subjects were smokers, and oral contraceptives were used by 46% of the female subjects. The age and the body mass index of the

Results

The mean intakes of the selected foods and nutrients of the habitual diet are shown in Table 1, Table 2, respectively. Female subjects consumed more fruits and tea than the male subjects (Table 1). Apart from total flavonoids and quercetin, the differences between sexes in nutrient intakes disappeared after adjusting with energy indicating that quality of the diet was similar between the sexes (Table 2). The levels of biochemical parameters related to oxidative stress or lipid peroxidation as

Discussion

The aim of the present study was to investigate if the composition of a habitual diet in free living subjects is reflected in the levels of currently available indicators of lipid peroxidation and oxidative stress. Our results show that the indicators that are most often used, e.g. markers related to LDL oxidation in vitro or LDL levels of malondialdehyde, do not reflect the intake of oxidizable dietary components (like PUFAs) and hardly reflect the intake of protective antioxidative compounds

References (43)

M.I. Mackness et al.
Protection of low density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
Atherosclerosis
(1993)
A.N. Klimov et al.
Antioxidative activity of high-density lipoprotein in vivo
Atherosclerosis
(1993)
J. Eritsland
Safety considerations of polyunsaturated fatty acids
Am. J. Clin. Nutr. (Supplement)
(2000)
A. Turpeinen et al.
A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans
Prostag. Leukot. Ess. Fatty Acids
(1998)
S. Basu et al.
Conjugated linoleic acid induces lipid peroxidation in humans
FEBS Lett.
(2000)
M.R. McCall et al.
Can antioxidant vitamins materially reduce oxidative damage in humans?
Free Radic. Biol. Med.
(1999)
A.M. Louheranta et al.
Linoleic acid intake and susceptibility of very-low-density and low-density lipoproteins to oxidation in men
Am. J. Clin. Nutr.
(1996)
K. Marangon et al.
Diet, antioxidant status, and smoking habits in French men
Am. J. Clin. Nutr.
(1998)
M. El-Saadani et al.
A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent
J. Lipid Res.
(1989)
L. Cominacini et al.
A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalysed oxidative modification
J. Lipid Res.
(1991)

C.R. Wade et al.

Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxy radicals on the quantitation of plasma lipid peroxides

Life Sci.

(1988)

I. Salminen et al.

Dietary trans fatty acids increase conjugated linoleic acid levels in human serum

J. Nutr. Biochem.

(1998)

E. Barrett-Connor

Nutrition epidemiology: how do we know what they ate?

Am. J. Clin. Nutr.

(1991)

M.I. Mackness et al.

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

Atherosclerosis

(1991)

M. Aviram et al.

Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein preserved by antioxidants

Free Radic. Biol. Med.

(1999)

R. Schiavon et al.

Serum paraoxonase activity is decreased in uremic patients

Clin. Chim. Acta

(1996)

M.I. Mackness et al.

Low serum paraoxonase: a risk factor for atherosclerosis

Chem.-Biol. Interact.

(1999)

E. Nishio et al.

Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols

Biochem. Phys. Res. Commun.

(1997)

A.D. Watson et al.

Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein

J. Clin. Invest.

(1995)

D.M. Stafforini et al.

The platelet activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein

Trans. Assoc. Am. Phys.

(1993)

J. Nair et al.

High dietary ω-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects

Cancer Epidemiol. Biomarkers

(1997)

Cited by (93)

Relationship between lipoprotein (a) and subclinical carotid atherosclerosis in asymptomatic individuals
2022, Clinics
Citation Excerpt :
C-Reactive Protein (CRP) was measured by immunoturbidimetry using the Tina-quant® CRP (latex) high-sensitivity assay (Roche Diagnostics®, Mannheim, Germany). Plasma Paraoxonase-1 activity (PON1) was evaluated through an enzymatic method using paraoxon (diethyl-p-nitrophenylphosphate, Sigma, St. Louis, MO) as substrate.23 The determinations of cIMT and plaques were performed by a single trained radiologist, blind to the study participants.
This study aimed to evaluate the associations between Lipoprotein (a) ‒ Lp(a) levels and carotid Intima-Media Thickness (cIMT) and with carotid plaques in healthy subjects because of previous contradictory data.
A total of 317 healthy normolipidemic subjects (20‒77 years old) were selected. The cIMT and atherosclerotic plaques were determined by B-mode ultrasonography. Mann-Whitney tests were performed to compare the groups according to Lp(a) levels and to explore the associations between Lp(a), carotid plaques, and cIMT, logistic and linear regression analyses were performed.
Studied population (51% females, median age 43 years old) presented carotid plaques and cIMT ≥ 0.9 mm in 23% and 18% of the participants, respectively. The group with Lp(a) levels > 30 mg/dL presented significantly higher age and atherosclerotic plaques. Indeed, multivariate linear regression analysis showed a significant association between Lp(a), age, and race. On the other hand, logistic regression analysis demonstrated that the subjects with Lp(a) > 30 mg/dL have a significantly high risk of carotid plaques.
The data from the present study indicate that Lp(a) levels above 30 mg/dL contribute to the development of carotid plaques even in apparently healthy participants.
Phenotypes and concentration of PON1 in cardiovascular disease: The role of nutrient intake
2020, Nutrition, Metabolism and Cardiovascular Diseases
Citation Excerpt :
Epidemiological studies have revealed a relationship between a reduced risk of CVD and fruit consumption [10,42]. However, a study of a habitual diet conducted by Kleemola et al. [43] in healthy volunteers demonstrated a negative correlation of PON1 activity with the intake of vegetables, total and water-soluble fiber, as well as the intake of beta-carotene. The polyphenols present in wine, tea, and fruit juice exert an effect on PON1 activity in both humans and mice [44].
Paraoxonase 1 (PON1) is considered to play a crucial role as an anti-atherosclerotic factor. The PON1 activity is affected by genetic polymorphisms, environmental factors, age, sex, lifestyle, pharmaceutical drugs, and dietary factors. The aim of this study was to evaluate the association between macro- and micronutrients as well as PON1 concentration and activities in patients with cardiovascular diseases (CVD), cardiovascular risk factors but no CVD (CRF), and in healthy controls (control group).
A case-control study was carried out with 356 volunteers from the Mexican Institute of Social Security, Mexico. Clinical parameters, lipid profile, PON1 activities (AREase, LACase, CMPAase and PONase), and PON1 concentration were evaluated. There was a differential intake of macro- and micronutrients among the study groups. The intake of proteins and carbohydrates was higher in the CVD group than in the CFR and control groups (p < 0.05). AREase, LACase, and CMPAase activities and PON1 concentration were lowest in the CVD group.
LACase and CMPAase activities, as well as PON1 concentration, could be included in the battery of CVD predictive biomarkers in the Mexican population.
Fasting reveals largely intact systemic lipid mobilization mechanisms in respiratory chain complex III deficient mice
2020, Biochimica et Biophysica Acta - Molecular Basis of Disease
Mice homozygous for the human GRACILE syndrome mutation (Bcs1l^c.A232G) display decreased respiratory chain complex III activity, liver dysfunction, hypoglycemia, rapid loss of white adipose tissue and early death. To assess the underlying mechanism of the lipodystrophy in homozygous mice (Bcs1l^p.S78G), these and wild-type control mice were subjected to a short 4-hour fast. The homozygotes had low baseline blood glucose values, but a similar decrease in response to fasting as in wild-type mice, resulting in hypoglycemia in the majority. Despite the already depleted glycogen and increased triacylglycerol content in the mutant livers, the mice responded to fasting by further depletion and increase, respectively. Increased plasma free fatty acids (FAs) upon fasting suggested normal capacity for mobilization of lipids from white adipose tissue into circulation. Strikingly, however, serum glycerol concentration was not increased concomitantly with free FAs, suggesting its rapid uptake into the liver and utilization for fuel or gluconeogenesis in the mutants. The mutant hepatocyte mitochondria were capable of responding to fasting by appropriate morphological changes, as analyzed by electron microscopy, and by increasing respiration. Mutants showed increased hepatic gene expression of major metabolic controllers typically associated with fasting response (Ppargc1a, Fgf21, Cd36) already in the fed state, suggesting a chronic starvation-like metabolic condition. Despite this, the mutant mice responded largely normally to fasting by increasing hepatic respiration and switching to FA utilization, indicating that the mechanisms driving these adaptations are not compromised by the CIII dysfunction.
Bcs1l mutant mice with severe CIII deficiency, energy deprivation and post-weaning lipolysis respond to fasting similarly to wild-type mice, suggesting largely normal systemic lipid mobilization and utilization mechanisms.
The role of paraoxonase in cancer
2019, Seminars in Cancer Biology
Citation Excerpt :
Contrasting studies have been published about the effect of liposoluble and hydrosoluble vitamins on PON1 activity [162–165]. Population-based studies have shown a negative correlation[165], whereas there is also evidence of a positive correlation [162,163]. A recent review analyzed the impact of Mediterranean diet on PON1 status [166].
The paraoxonase (PON) gene family includes three proteins, PON1, PON2 and PON3. PON1 and PON3 are both associated with high-density lipoprotein (HDL) particles and exert anti-oxidant and anti-inflammatory properties. PON2 and PON3 are intracellular enzymes which modulate mitochondrial superoxide anion production and endoplasmic reticulum (ER) stress-induced apoptosis. The pleiotropic roles exerted by PONs have been mainly investigated in cardiovascular and neurodegenerative diseases. In recent years, overexpression of PON2 and PON3 has been observed in cancer cells and it has been proposed that both enzymes could be involved in tumor survival and stress resistance. Moreover, a lower activity of serum PON1 has been reported in cancer patients. This review summarizes literature data on the role of PONs in human cancers and their potential role as a target for antitumor drugs.
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism
2016, Journal of Lipid Research
The consequences of angiopoietin-like protein 3 (ANGPTL3) deficiency on postprandial lipid and lipoprotein metabolism has not been investigated in humans. We studied 7 homozygous (undetectable circulating ANGPTL3 levels) and 31 heterozygous (50% of circulating ANGPTL3 levels) subjects with familial combined hypolipidemia (FHBL2) due to inactivating ANGPTL3 mutations in comparison with 35 controls. All subjects were evaluated at fasting and during 6 h after a high fat meal. Postprandial lipid and lipoprotein changes were quantified by calculating the areas under the curve (AUCs) using the 6 h concentration data. Plasma changes of β-hydroxybutyric acid (β-HBA) were measured as marker of hepatic oxidation of fatty acids. Compared with controls, homozygotes showed lower incremental AUCs (iAUCs) of total TG (−69%, P < 0.001), TG-rich lipoproteins (−90%, P < 0.001), apoB-48 (−78%, P = 0.032), and larger absolute increase of FFA (128%, P < 00.1). Also, heterozygotes displayed attenuated postprandial lipemia, but the difference was significant only for the iAUC of apoB-48 (−28%; P < 0.05). During the postprandial period, homozygotes, but not heterozygotes, showed a lower increase of β-HBA. Our findings demonstrate that complete ANGPTL3 deficiency associates with highly reduced postprandial lipemia probably due to faster catabolism of intestinally derived lipoproteins, larger expansion of the postprandial FFA pool, and decreased influx of dietary-derived fatty acids into the liver. These results add information on mechanisms underlying hypolipidemia in FHBL2.
A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity
2016, Atherosclerosis
Among subjects with high-density-lipoprotein cholesterol (HDL-C) below the 1st percentile in the general population, we identified a heterozygous variant OSBPL1A p.C39X encoding a short truncated protein fragment that co-segregated with low plasma HDL-C.
We investigated the composition and function of HDL from the carriers and non-carriers and studied the properties of the mutant protein in cultured hepatocytes.
Plasma HDL-C and apolipoprotein (apo) A-I were lower in carriers versus non-carriers, whereas the other analyzed plasma components or HDL parameters did not differ. Sera of the carriers displayed a reduced capacity to act as cholesterol efflux acceptors (p < 0.01), whereas the cholesterol acceptor capacity of their isolated HDL was normal. Fibroblasts from a p.C39X carrier showed reduced cholesterol efflux to lipid-free apoA-I but not to mature HDL particles, suggesting a specific defect in ABCA1-mediated efflux pathway. In hepatic cells, GFP-OSBPL1A partially co-localized in endosomes containing fluorescent apoA-I, suggesting that OSBPL1A may regulate the intracellular handling of apoA-I. The GFP-OSBPL1A-39X mutant protein remained in the cytosol and failed to interact with Rab7, which normally recruits OSBPL1A to late endosomes/lysosomes, suggesting that this mutation represents a loss-of-function.
The present work represents the first characterization of a human OSBPL1A mutation. Our observations provide evidence that a familial loss-of-function mutation in OSBPL1A affects the first step of the reverse cholesterol transport process and associates with a low HDL-C phenotype. This suggests that rare mutations in OSBPL genes may contribute to dyslipidemias.

View all citing articles on Scopus

View full text

Dietary determinants of serum paraoxonase activity in healthy humans

Abstract

Introduction

Section snippets

Subjects

Results

Discussion

Atherosclerosis

Atherosclerosis

Am. J. Clin. Nutr. (Supplement)

Prostag. Leukot. Ess. Fatty Acids

FEBS Lett.

Free Radic. Biol. Med.

Am. J. Clin. Nutr.

Am. J. Clin. Nutr.

J. Lipid Res.

J. Lipid Res.

Life Sci.

J. Nutr. Biochem.

Am. J. Clin. Nutr.

Atherosclerosis

Free Radic. Biol. Med.

Clin. Chim. Acta

Chem.-Biol. Interact.

Biochem. Phys. Res. Commun.

Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein

J. Clin. Invest.

The platelet activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein

Trans. Assoc. Am. Phys.

High dietary ω-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects

Cancer Epidemiol. Biomarkers